Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 22 pseudogene 4 (RBM22P4) is a genomic pseudogene related to the protein-coding RBM22 gene. While RBM22 plays a critical role in pre-mRNA splicing within the spliceosome complex and is important for gene expression regulation, RBM22P4 itself does not encode a functional protein and has no confirmed biological functions, disease associations, or therapeutic relevance. There are no known drugs, biomarkers, or clinical safety considerations linked to RBM22P4. Its designation as a pseudogene means it is typically excluded from lists of drug targets or receptors[1][2][3].
None. No drug mechanisms are relevant for RBM22P4.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 22 pseudogene 4 (RBM22P4).